Search Results 111-120 of 21426 for anti-TNF drugs

  1. GLP-1 agonists: Diabetes drugs and weight loss - Mayo Clinic

    The drugs already discussed are indicated in people living with type 2 diabetes. There is also a drug that has a higher dose of liraglutide (Saxenda) that's ...

  2. AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Anti-TNF agents; Corticosteroids (non-US sites only). Neurological exam free ...

  3. centers-of-excellence

    Adalimumab-Adbm (Subcutaneous Route) Before Using - Mayo Clinic. Skip to content Care at Mayo Clinic Patient-Centered Care About Mayo ...

  4. Publications - Konstantinos A. Papadakis, M.D. - Mayo Clinic

    Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists. J Crohns ...

  5. Inflammatory bowel disease biobank research update - Mayo Clinic

    ... anti-tumor necrosis factor (TNF) therapy. They examined how a patient's genetic risk burden or profile affects the disease course and individual responses ...

  6. Prior authorization process can have multiple negative impacts for gastroenterologists and patients with inflammatory bowel disease - Mayo Clinic

    ... agents and small-molecule drugs, early in the course of disease. ... Examining clinical and genetic factors that impact response to anti-TNF agents in patients ...

  7. NSAIDs: Do they increase my risk of heart attack and stroke? - Mayo Clinic

    Answer From Rekha Mankad, M.D.. Yes. Nonsteroidal anti-inflammatory drugs (NSAIDs) — medications commonly used to treat pain and inflammation — can increase the ...

  8. Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles ... Previously received a positive ...

  9. A Study to Evaluate the Effectiveness and Safety of Triple Combination Therapy in High Risk Crohn's Disease (CD) - Mayo Clinic

    ... anti-integrin (vedolizumab intravenous [IV]), a tumor necrosis factor (TNF) antagonist (adalimumab subcutaneously [SC]), and an immunomodulator (oral ...

  10. Publications - Lynne S. Peterson, M.D. - Mayo Clinic

    ... anti-TNF therapy (poster presentation). European League Against Rheumatism (EULAR).2004;; Peterson LS, Mason T, Mason T, Nelson AM, O'Fallon WM, Gabriel SE ...